Yoshimura Noriko, Sasada Tatsunari, Yonehara Shuji
Department of Surgery, Onomichi General Hospital, Hiroshima, Japan.
Department of Pathology, Onomichi General Hospital, Hiroshima, Japan.
Breast Care (Basel). 2015 Aug;10(4):281-3. doi: 10.1159/000431070. Epub 2015 May 29.
Primary large-cell neuroendocrine carcinoma of the breast (LCNEC-breast) in pre-menopausal women is extremely rare.
A 34-year-old woman presented with a mass in the left breast that was diagnosed as neuroendocrine carcinoma by needle biopsy. Computed tomography revealed no lymph node swelling or distant organ metastasis. Left mastectomy and sentinel lymph node biopsy were performed and metastasis to the axial lymph node was detected. Left axillary lymph node dissection was performed and histopathological and immunohistochemical examination revealed that the tumor was an LCNEC-breast, which was 6.0 cm in size and positive for the neuroendocrine markers (neuron-specific enolase, chromogranin A, and synaptophysin). The tumor cells were hormone-receptor positive and HER2 negative. The patient refused any adjuvant hormonal therapy, chemotherapy or radiotherapy. She has been followed up for 4 years without medication, and no recurrence has been noted.
We present a case of LCNEC-breast in a 34-year-old woman. Our case represents the youngest woman with LCNEC-breast reported in the English literature.
绝经前女性原发性乳腺大细胞神经内分泌癌(LCNEC-乳腺)极为罕见。
一名34岁女性因左乳肿块就诊,针吸活检诊断为神经内分泌癌。计算机断层扫描显示无淋巴结肿大或远处器官转移。行左乳切除术及前哨淋巴结活检,发现腋窝淋巴结转移。行左腋窝淋巴结清扫术,组织病理学和免疫组织化学检查显示肿瘤为LCNEC-乳腺,大小为6.0 cm,神经内分泌标志物(神经元特异性烯醇化酶、嗜铬粒蛋白A和突触素)呈阳性。肿瘤细胞激素受体阳性,HER2阴性。患者拒绝任何辅助激素治疗、化疗或放疗。她已停药随访4年,未发现复发。
我们报告了一例34岁女性的LCNEC-乳腺病例。我们的病例是英文文献中报道的最年轻的LCNEC-乳腺女性患者。